Search by PubMed Identification
PMID | Data | Article Title | Citation | Organization | Data Download |
---|---|---|---|---|---|
34665619 | 189 | Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity. | J Med Chem (2021) | TBA | 2D 3D TSV |
34651447 | 87 | A patent review on SARS coronavirus main protease (3CLpro) inhibitors. | ChemMedChem (2021) | Experimental Drug Development Centre | 2D 3D TSV |
34528437 | 44 | Indole Chloropyridinyl Ester-Derived SARS-CoV-2 3CLpro Inhibitors: Enzyme Inhibition, Antiviral Efficacy, Structure-Activity Relationship, and X-ray Structural Studies. | J Med Chem 64: 14702-14714 (2021) | Purdue University | 2D 3D TSV |
34426525 | 6 | DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 M | Proc Natl Acad Sci U S A 118: (2021) | Baylor College of Medicine | 2D 3D TSV |
34414360 | 60 | Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and Boceprevir. | ACS Pharmacol Transl Sci 4: 1408-1421 (2021) | The University of Arizona | 2D 3D TSV |
34408808 | 72 | Optimization of Triarylpyridinone Inhibitors of the Main Protease of SARS-CoV-2 to Low-Nanomolar Antiviral Potency. | ACS Med Chem Lett 12: 1325-1332 (2021) | Yale University | 2D 3D TSV |
34347470 | 98 | Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CL | J Med Chem 64: (2021) | Cleveland Clinic | 2D 3D TSV |
34271072 | 34 | A head-to-head comparison of the inhibitory activities of 15 peptidomimetic SARS-CoV-2 3CLpro inhibitors. | Bioorg Med Chem Lett 48: 128263 (2021) | A*STAR | 2D 3D TSV |
34242027 | 24 | Peptidomimetic ?-Acyloxymethylketone Warheads with Six-Membered Lactam P1 Glutamine Mimic: SARS-CoV-2 3CL Protease Inhibition, Coronavirus Antiviral Activity, and | J Med Chem (2021) | University of Alberta | 2D 3D TSV |
34213885 | 38 | Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease. | J Med Chem 64: 10047-10058 (2021) | Wichita State University | 2D 3D TSV |